Real-time enrollment status for this x-linked severe combined immunodeficiency (xscid) clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 7:42 AM UTC
| NCT Number | NCT01306019 |
| Recruiting Status | Recruiting |
| Condition | X-linked Severe Combined Immunodeficiency (XSCID) |
| Phase | PHASE1 |
| Target Enrollment | 40 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Last Updated on CT.gov | August 31, 2026 (Yesterday) |
As of September 1, 2026: Clinical trial NCT01306019 is currently recruiting participants. This phase1 study for x-linked severe combined immunodeficiency (xscid) is actively seeking new participants at 1 location across the United States. The study is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT01306019 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT01306019 was last updated Yesterday (August 31, 2026). HelloStudys verifies this status automatically.